CBH

Home / Publications

Publications

Invited talks

Nanjing Medical University, Dec. 2012, Nanjing, China
MicroRNA in Cancer

CancerScience/Biomarker meeting, Nov. 2013, San Francisco, USA
Biomarker HUNT in asbestos related diseases

Springmeeting Lungcancer 15th May 2014, Oslo, Norway
Mesothelioma- New research of a forgotten epidemic

“MicroRNAs/Noncoding RNAs Europe 2014, November 3 - 4, 2014 University of Cambridge, Cambridge, United Kingdom
MicroRNAs in serum for early diagnosis of cancer. Where are we?

2nd NordiQC Conference on Applied Immunohistochemistry
June 9th - 12th 2015 Aalborg, Denmark
Malignant mesothelioma – epidemiology and molecular biology

3rd “Symposium on Thoracic and Upper Aerodigestive Malignancies” February 5-7, 2015 Athens, Greece
Biomarkers for early diagnosis of lung cancer and mesothelioma

4th “Symposium on Thoracic and Upper Aerodigestive Malignancies” April 7-8, 2015 Athens, Greece
Circulating biomarkers for mesothelioma

“MicroRNAs/Noncoding RNAs & Genome Editing Europe 2015” meeting, Cambridge, UK, 2 -3. November 2015.
Early diagnosis of lung cancer and mesothelioma by multi-omics, techniques and feasibility

Translational oncology meeting, Heraklion Crete, 16. Nov. 2016
Early diagnosis of lung cancer-the Cancer in Biomarkers in HUNT project

5th “Symposium on Thoracic and Upper Aerodigestive Malignancies” April, 2017 Athens, Greece
Prognostic factors for mesothelioma

Thoracic oncology dept., Bank of Cyprus Cancer Center, Nicosia, Cyprus, May 04 2017
Asbestos, lung cancer and mesothelioma – Status, future and current research

Laboratory of Carcinogenesis, National Cancer Institute (NCI), Bethesda, Washington, USA, June 07th 2017
Asbestos, lung cancer and mesothelioma – Status, future and current research

Association of palliative nurses of North Denmark, Aalborg, April 17Asbest,
Lungekræft og mesotheliom – Historie, status, forskning og fremtid.

Nordic Thoracic Oncology Group (NTOG) Vasa, Finland, April 22.
MesotheliomaBiomarkers

Oral presentations

Hvidsten M, Røe OD Asbestos disease research in former Soviet Union and Russia; Literature comparisons with United Kingdom and Japan.
MIG 2018, 2-5th May, Ottawa, Canada

Røe OD Cancer-Biomarkers in HUNT study: Early diagnostic poly-markers in lung cancer and mesothelioma
1st International NTNU Symposium on Current and Future Clinical Biomarkers of Cancer: Innovation and Implementation
June 16th-17th 2016, Trondheim, Norway

Panou V, Mogens V, Meristoudis C, Røe OD
BAP-1 cancer syndrome associated malignancies were not detected among 558 Danish patients with malignant mesothelioma,
IMIG, May 2016, UK

Panou V, Omland Ø, Meristoudis C, Hoffmann L, Røe OD
Degree of asbestos exposure predisposes to pleural or peritoneal disease in women: Malignant mesothelioma in a female population in North Jutland, Denmark
IASLC, sept. 2015, Denver, USA

Panou V, Omland Ø, Langhoff MD, Meristoudis C, Weinreich UM1, Røe OD
Malignant mesothelioma in women in the Region of North Jutland, Denmark; Non-Occupational asbestos exposure in more than 50% of the cases.
IMIG 2014, Cape Town, South Africa

Published abstracts (project related)

Vasiliki Panou, Christos Meristoudis, Ulla M. Weinreich, Oluf D. Røe, Mogens Vyberg.
IMPACT OF CALRETININ IMMUNOHISTOCHEMISTRY AND THE IMIG GUIDELINES IN THE MALIGNANT MESOTHELIOMA DIAGNOSIS

OD Røe, Ø Omland, V Panou, A Wannag
Asbestos consumtion, Eternit and pleural mesothelioma in Norway and Denmark: Similar populations, different stories.
IMIG 2018, 2-5th May, Ottawa, Canada

V Panou, UM Weinreich, J Bak, M Vyberg, C Meristoudis, O Omland, OD Roe, J Hansen
Gender differences in asbestos exposure and disease location in 327 patients with mesothelioma
European Respiratory Journal 2017 50: PA4294; DOI: 10.1183/1393003.congress-2017.PA4294

OD Røe, M. Markaki, I. Tsamardinos, A. Langhammer, V. Lagani, K. Hveem. A Validated Clinical Lung Cancer Risk-Prediction Model for Light-, Heavy- and Ex-Smokers: the HUNT Lung Cancer Model,
IASLC 18th World Conference on Lung Cancer, Oct. 2017, Yokohama,

OD Røe, R. Mjelle, H.F. Kvitvang, I. Tsamardinos, M. Markaki3O.T.D. Nguyen, V. Lagani Metabolic Biomarkers in Serum for the Early Diagnosis of Lung Cancer: First Results from the Cancer-Biomarkers in HUNT Initiative,
IASLC 18th World Conference on Lung Cancer, Oct. 2017, Yokohama, Japan

Panou V, Vyberg M, Meristoudis C, Omland Ø, Weinreich UM ,Hansen J, Røe OD
Malignant mesothelioma in 91 Danish women - the environmental asbestos exposure
ASCO, Chicago, USA June 2017, J Clin Oncol (Poster 8560)

Røe OD, Lagani V, Kvitvang HF, Markaki M, Tsamardinos I, Mjelle R
Metabolomics signature in serum months to years before thoracic cancer: The HUNT study.
ASCO, Chicago, USA June 2017, J Clin Oncol (Abstr e23059)

Panou V, Nielsen I, Sørensen JB, Røe OD,
Pemetrexed as first or second line in 112 Danish patients.
ASCO, Chicago, USA June 2016, J Clin Oncol 34, 2016 (suppl; abstr e20084)

OD Røe, Robin Mjelle, Maria Markaki, Trygve Andreassen, Vincenzo Lagani, Ioannis Tsamardinos, Tone Bathen, Pål Sætrom, Kristian Hveem
Serum microRNAs/enriched pathways in lung cancer 1-4 years before diagnosis: A pilot study from the HUNT Biobank, Norway.
ASCO, Chicago, USA June 2016, J Clin Oncol 34, 2016 (suppl; abstr 11539)

Robin Mjelle, Maria Markaki, Trygve Andreassen, Vincenzo Lagani, Ioannis Tsamardinos, Tone Bathen, Pål Sætrom, Kristian Hveem, Oluf D. Røe:
Serum biomarkers in mesothelioma 1-3 years before diagnosis-a pilot study,
IMIG 2016 in Birmingham

Kerkentzes K, Mjelle R, Røe OD
MicroRNA miR-615-3p and let-7b targets multiple key pathways overexpressed in lung adenocarcinoma
IASLC 2015, Denver, USA

Gao Zhibin, Kenzo Hiroshima, Oluf Dimitri Røe, Kenji Morinaga
Asbestos textile production linked to malignant peritoneal and pleural mesothelioma in women: Analysis of 28 cases in Southeast China
IMIG 2014, Cape Town

Panou V, Omland Ø, Vyberg M, Røe OD
Overrepresentation of malignant peritoneal mesothelioma among females in a cohort of 296 danish patients
IMIG 2014, Cape Town

R Mjelle, T Andreassen, V Lagani, K Kerkentzes, I Tsamardinos, TF Bathen, E Larsson, OD Røe,
“Hunting” for lung-cancer / mesothelioma early diagnostic biomarkers: results of a pilot analysis from the Cancer-Biomarker-HUNT study.
IMIG 2014, Cape Town

Oluf Dimitri Røe, Bjørn Edin Røe
AC- International Asbestos Cement Review 1955-78: The asbestos industry using world-renowned architects to showcase and increase popularity of asbestos construction materials.
IMIG 2014, Cape Town

Panou Vasiliki, Meristoudis Christos, Røe Oluf Dimitri
Malignant mesothelioma in Aalborg, North Denmark. Pathology records of the Aalborg University Hospital reveal 562 cases and a 13-fold increase in four decades
European Congress of Pathology, 2014.

Wu Chen, Xiaofei Zhi, Duan Chen, Yijiang Chen, Oluf Dimitri Røe
DNA repair suppression and effect of cisplatin in mesothelioma and lung cancer cell lines.
ASCO, J Clin Oncol 31, 2013 (suppl; abstr e13542)

Dimitris Vainas, Oluf Dimitri Røe, Vincenzo Lagani
Comparative evaluation of Affymetrix and Illumina genome-wide expression data in Pleural Mesothelioma, Proceedings of the 7th conference of the Hellenic Society for Computational Biology & Bioinformatics - HSCBB12 FORTH, Heraklion, Crete, Greece, 4-6/10/2012

O. D. Roe, E. Anderssen, E. Helge, C. H. Pettersen, H. Sandeck, E. Larsson, S. Lundgren
Overexpression of a set of genes in mesothelioma versus parietal pleura may explain its chemo- and radio-resistance. ASCO 2008, Chicago, USA Abstract No: 13506 J Clin Oncol 26: 2008 (May 20 suppl; abstr 13506)

Related publications

2018

Environmental asbestos exposure in childhood and the risk of mesothelioma later in life. A long-term follow-up register based cohort study. Sofie Bünemann Dalsgaard, Else Toft Würtz, Johnni Hansen Oluf Dimitri Røe, Øyvind Omland (in press) Occupational and Environmental Health, 2018

Røe OD, Asbestos and mesothelioma in Denmark 2017: status of a man-made cancer epidemic. Ugeskr Læger 2018;180:V02180128

Szejniuk WM, Robles AI, McCulloch T, Falkmer UGI, Røe OD. Epigenetic predictive biomarkers for response or outcome to platinum-based chemotherapy in non-small cell lung cancer, current state-of-art. Pharmacogenomics J. 2018 Sep 7. doi: 10.1038/s41397-018-0029-1. [Epub ahead of print] Review.

Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma. Panou V, Gadiraju M, Wolin A, Weipert CM, Skarda E, Husain AN, Patel JD, Rose B, Zhang SR, Weatherly M, Nelakuditi V, Knight Johnson A, Helgeson M, Fischer D, Desai A, Sulai N, Ritterhouse L, Røe OD, Turaga KK, Huo D, Segal J, Kadri S, Li Z, Kindler HL, Churpek JE. J Clin Oncol. 2018 Aug 16:JCO2018785204. doi: 10.1200/JCO.2018.78.5204.

Panou V1, Vyberg M, Meristoudis C, Hansen J, Bøgsted M, Omland Ø, Weinreich UM, Røe OD. Non-occupational exposure to asbestos is the main cause of malignant mesothelioma in women in North Jutland, Denmark. Scand J Work Environ Health. 2018 Jul 19. pii: 3756. doi: 10.5271/sjweh.3756.

Røe OD. Mesothelioma diagnosis and prognosis, are we moving beyond histology and performance status towards circulating biomarkers? June 2018, Journal of Thoracic Disease 10(S16):S1956-S1961 DOI: 10.21037/jtd.2018.06.12

Markaki M, Tsamardinos I, Langhammer A, Lagani V, Hveem K, Røe OD. A Validated Clinical Risk Prediction Model for Lung Cancer in Smokers of All Ages and Exposure Types: A HUNT Study. EBioMedicine. 2018 Mar 30. pii: S2352-3964(18)30114-2. doi: 10.1016/j.ebiom.2018.03.027. [Epub ahead of print]

2017

Røe OD. Mesothelioma and mesothelin—an underused diagnostic biomarker becoming a treatment target, Shanghai Chest doi: 10.21037/shc.2017.11.07

J Sun, S He, P Lin, P Li, X Cai, L Li, J Qian, C Liu, X Li, Y Liu, OD Røe, Y Shu X Chen and Y Gu
Adjuvant Capecitabine and Oxaliplatin vs. Capecitabine and Paclitaxel in Gastric Cancer Patients after D2 Gastrectomy, Journal of Carcinogenesis & Mutagenesis, 8:306. doi: 10.4172/2157-2518.1000306

Wang Q, Chen Q, Zhu L, Chen M, Xu W, Panday S, Wang Z, Li A, Røe OD, Chen R, Wang S, Zhang R, Zhou J
Oncogenesis. 2017 Jul 3;6(7):e353. doi: 10.1038/oncsis.2017.57.
JWA regulates TRAIL-induced apoptosis via MARCH8-mediated DR4 ubiquitination in cisplatin-resistant gastric cancer cells.

Røe OD, Wahl GF, The undifferentiated carcinoma that became a melanoma: Why re-biopsy a CUP? A case report.
Journal of Medical Case Reports, Feb 2017 DOI: 10.1186/s13256-017-1238-y

2016

OD Røe
The High Cost of New Cancer Therapies—A Challenge of Inequality for All Countries
JAMA Oncol. Published online December 29, 2016. doi:10.1001/jamaoncol.2016.6335

Ana I. Robles, Karina Standahl Olsen, Dana W.T. Tsui, Vassilis Georgoulias, Jenette Creaney, Katalin Dobra, Mogens Vyberg, Nagahiro Minato, Robert A. Anders, Anne-Lise Børresen-Dale, Jianwei Zhou, Pål Sætrom, Boye Schnack Nielsen, Michaela B. Kirschner, Hans E. Krokan, Vassiliki Papadimitrakopoulou, Ioannis Tsamardinos and Oluf D. Røe
Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer: innovation and implementation, June 16th and 17th 2016, Trondheim, Norway
Journal of Translational Medicine201614:295 DOI: 10.1186/s12967-016-1059-6

2015

Z Gao, K Hiroshima, X Wu, J Zhang, D Shao, H Shao, H Yang, T Yusa, T Kiyokawa, M Kobayashi, Y Shinohara, OD Røe, X Zhang, K Morinaga
Asbestos textile production linked to malignant peritoneal and pleural mesothelioma in women: Analysis of 28 cases in Southeast China
American Journal of Industrial Medicine, 29 May 2015 doi 10.1002/ajim.22494

V Panou, M Vyberg, U M Weinreich, C Meristoudis, U Falkmer, O D Røe
The established and future biomarkers of malignant pleural mesothelioma
Cancer Treatment Reviews, May 2015, doi link

Oluf D. Røe, Giulia M. Stella
Malignant pleural mesothelioma- history, controversy, and future of a man-made epidemic; review.
Eur Respir Rev. 2015 Mar;24(135):115-131.

Zhu W, Røe OD, Wu C, Li W, Guo R, Gu Y, Liu Y, Shu Y, Chen X.
Pemetrexed-platinum regimen as first-line chemotherapy for adenocarcinoma of the lung with asymptomatic and inoperable brain metastasis: a retrospective study
J Chemother. 2015 Mar 3:1973947815Y0000000005. [Epub ahead of print]

2014
Wenxia Xu, Qi Chen, Qiang Wang, Yun Sun, Shouyu Wang, Aiping Li, Shan Xu, Oluf Dimitri Røe, Minghai Wang, Ruiwen Zhang, Liuqing Yang, Jianwei Zhou.
JWA reverses cisplatin resistance via the CK2—XRCC1 pathway in human gastric cancer cells
Cell Death and Disease (2014) 5, e1551; doi:10.1038/cddis.2014.517, Published online 4 December 2014

Røe OD, Oppegaard PA, Revheim ME, Svindland A
Adrenocortical cancer mimicking lung cancer and responding to vinorelbine, pemetrexed and carboplatin- a case report
BMJ Case Rep. 2014 Nov 12;2014. pii: bcr2014206225. doi: 10.1136/bcr-2014-206225.

K Kerkentzes, V Lagani, M Vyberg, I Tsamardinos, OD Røe
Hidden treasures in “ancient” microarrays: Gene expression portrays biology and potential resistance pathways of major lung cancer subtypes and normal tissue.
Front. Oncol. 4:251. doi:10.3389/fonc.2014.00251

Szejniuk WM, McCullock T, Røe OD
Effective ultra-low doses of erlotinib in patients with EGFR sensitizing mutation.
BMJ Case Rep. 2014 Jul 23;2014. pii: bcr2014204809. doi: 10.1136/bcr-2014-204809.

Xiaofeng Chen, Quan Zhu, Yiqian Liu, Ping Liu, Yongmei Yin, Renhua Guo, Kaihua Lu , Yanhong Gu , Lianke Liu, Jinghua Wang, Zhaoxia Wang, Oluf Dimitri Røe, Yongqian Shu & Lingjun Zhu
Icotinib is an active treatment of non-small-cell lung cancer: a retrospective study
PLoS One. 2014 May 16;9(5):e95897. doi: 10.1371/journal.pone.0095897. eCollection 2014.

Jianwei Zhou, Wenxia Xu, Shouyu Wang, Qi Chen, Yajie Zhang, Pan Ni, Xuming Wu, Jianbing Zhang, Fulin Qiang, Aiping Li, Oluf Dimitri Røe, Shan Xu, Minghai Wang, and Ruiwen Zhang. TXNL1-XRCC1 pathway regulates cisplatin induced cell death and contributes to resistance in human gastric cancer"
Cell Death Dis. 2014 Feb 13;5:e1055. doi: 10.1038/cddis.2014.27

2013
Caihua Xu, Chen Wu, Yang Xia, Zhaopeng Zhong,  Xiang Liu, Jing Xu,  Fei Cui, Bin Chen,  Oluf Dimitri Røe, Aihong Li, Yijiang Chen WT1 Promotes Cell Proliferation in Non-Small Cell Lung Cancer Cell Lines through Up-Regulating Cyclin D1 and p-pRb In Vitro and In Vivo,
PLoS One. 2013 Aug 1;8(8):e68837. doi: 10.1371/journal.pone.0068837. Print 2013.

XF Chen, YQ Liu, O.D. Røe, YY Qian, RH Guo, LJ Zhu, YM Yin, YQ Shu
Gefitinib or erlotinib as maintenance therapy in patients with advanced stage non-small cell lung cancer: A systematic review.
PLoS One. 2013;8(3):e59314. doi: 10.1371/journal.pone.0059314. Epub 2013 Mar 21. Review.

Ye Y, Li X, Yang J, Miao S, Wang S, Chen Y, Xia X, Wu X, Zhang J, Zhou Y, He S, Tan Y, Qiang F, Li G, Røe OD, Zhou J. MDM2 is a useful prognostic biomarker for resectable gastric cancer.
Cancer Sci. 2013 May;104(5):590-8. doi: 10.1111/cas.12111. Epub 2013Mar 5

Chen Y, Xia X, Wang S, Wu X, Zhang J, Zhou Y, Tan Y, He S, Qiang F, Li A, Røe OD, Zhou J. High FAK combined with low JWA expression: clinical prognostic and predictive role for adjuvant fluorouracil–leucovorin–oxaliplatin treatment in resectable gastric cancer patients
J Gastroenterol. 2013 Sep;48(9):1034-44. doi: 10.1007/s00535-012-0724-7. Epub 2013 Jan 11

2012
Liu X, Wang S, Xia X, Chen Y, Zhou Y, Wu X, Zhang J, He S, Tan Y, Qiang F, Røe OD, Li G, Zhou J. Synergistic Role between p53 and JWA: Prognostic and Predictive Biomarkers in Gastric Cancer.
PLoS One. 2012;7(12):e52348. doi: 10.1371/journal.pone.0052348. Epub 2012 Dec 21.

Xiaofeng Chen, Xiaoming Zha, Wei Chen, Tingting Zhu, Jinrong Qiu, Oluf Dimitri Røe, Jun Li, Zhaoxia Wang , Yongmei Yin Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer,
Biomed Pharmacother. 2013 Feb;67(1):22-30. doi: 10.1016/j.biopha.2012.10.001. Epub 2012 Nov 15.

Xiao-feng Chen, Guo-qiang Ping, Shi-dai Jin,Rong Wang, Ke-li Yan, Oluf Dimitri Røe, Yong-qian Shu, Ren-hua Guo, Case report: Recombinant human endostatin (endostar) decreased recurrent ascites, pleural fluid and ascitic VEGF in a case of advanced mesothelioma,
J Chemother. 2012 Aug;24(4):231-6. doi: 10.1179/1973947812Y.0000000023.

Oluf Dimitri Røe, Adam Szulkin, Helmut Sandeck, Endre Anderssen, Tore Amundsen, Sten Even Erlandsen, Katalin Dobra, Stein Harald Sundstrøm, Molecular Resistance Fingerprint of Pemetrexed and Platinum in a Long-Term Survivor of Mesothelioma.
PLoS One. 2012;7(8):e40521. doi: 10.1371/journal.pone.0040521. Epub 2012 Aug 8.

Shouyu Wang, Xuming Wu, Jianbing Zhang, Yansu Chen, Jin Xu, Xiaowei Xia, Song He, Fulin Qiang, Aiping Li, Yongqian Shu, Oluf Dimitri Røe, Gang Li, and Jianwei Zhou: CHIP functions as a novel suppressor of tumor angiogenesis with prognostic significance in human gastric cancer.
Gut. 2013 Apr;62(4):496-508. doi: 10.1136/gutjnl-2011-301522. Epub 2012 Apr 25.

Wang S, Wu X, Chen Y, Zhang J, Ding J, Zhou Y, He S, Tan Y, Qiang F, Bai J, Zeng J, Gong Z, Li A, Li G, Røe OD, Zhou J. Prognostic and predictive role of JWA and XRCC1 expression in gastric cancer,
Clin Cancer Res. 2012 May 15;18(10):2987-96. doi: 10.1158/1078-0432.CCR-11-2863. Epub 2012 Mar 27.

Chen XF, Wang R, Yin YM, Røe OD, Li J, Zhu LJ, Guo RH, Wu T, Shu YQ. The effect of monosialotetrahexosylganglioside (GM1) in prevention of oxaliplatin induced neurotoxicity: A retrospective study. Biomed Pharmacother. 2012 Jun;66(4):279-84. doi: 10.1016/j.biopha.2012.01.002. Epub 2012 Feb 17.

2011
I. Tsamardinos, G. Borboudakis, E. G. Christodoulou, O. D. Røe: Chemosensitivity Prediction of Tumours Based on Expression, miRNA, and Proteomics Data, (Invited paper CIAB (Computational Intelligence Applications in Bioinformatics) Workshop (12th EANN(IEEE) /7th AIAI (IFIP), April 2011)

2010
Sandeck HP, Røe OD, Kjærheim K, Willén H, Larsson E. Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry.
Diagn Pathol. 2010 Jul 6;5:47. doi: 10.1186/1746-1596-5-47.

Røe OD, Anderssen E, Sandeck H, Christensen T, Larsson E, Lundgren S.
Malignant pleural mesothelioma: Genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targets.
Lung Cancer. 2010 Jan;67(1):57-68. doi: 10.1016/j.lungcan.2009.03.016. Epub

2009
Oluf D. Røe, Endre Anderssen, Eli Helge, Caroline Hild Hakvaag Pettersen, Karina Standahl Olsen, Helmut Sandeck, Rune Haaverstad, Steinar Lundgren, Erik Larsson, Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: The emerging gene portrait of the mesothelioma phenotype.
PLoS One. 2009 Aug 7;4(8):e6554. doi: 10.1371/journal.pone.0006554.

2008
Røe OD, Creaney J, Lundgren S, Larsson E, Sandeck H, Boffetta P, Nilsen TI, Robinson B, Kjaerheim K. Mesothelin-related predictive and prognostic factors in malignant mesothelioma: A nested case-control study.
Lung Cancer. 2008 Aug;61(2):235-43. doi: 10.1016/j.lungcan.2007.12.025. Epub 2008 Feb 20.

2007
Kjaerheim K, Røe OD, Waterboer T, Sehr P, Rizk R, Dai HY, Sandeck H, Larsson E, Anderssen A, Boffetta P, Pawlita M. Absence of SV40 antibodies or DNA fragments in prediagnostic mesothelioma serum samples.
Int J Cancer. 2007 Jun 1;120(11):2459-65.

Proceedings (full-paper reviewed)

Christodoulou, E. G., Røe, O. D., Folarin, A., & Tsamardinos, I. (2011). Information-Preserving Techniques Improve Chemosensitivity Prediction of Tumours Based on Expression Profiles. 12th Engineering Applications of Neural Networks (EANN) / 7th Artificial Intelligence Applications and Innovations (AIAI) joint conferences, Workshop on Computational Intelligence Applications in Bioinformatics (CIAB 2011). 15-18 September, Corfu, Greece. (pp. 453-462). Springer Boston

Tsamardinos, I., Røe, O. D., & Lagani, V. (2011). Introducing Integrative Causal Analysis for Co-Analyzing Heterogeneous Studies with an Application to Methylation and Gene Expression Mesothelioma Cancer Data. 6th Conference of the Hellenic Society for Computational Biology and Bioinformatics (HSCBB11). October, Patras, Greece.

Thesis Røe OD, Malignant Mesothelioma: Virus, Biomarkers and Genes - a Translational Approach. PhD Thesis. Norwegian University of Science and Technology, Faculty of Medicine, Institute of Cancer Research and Molecular Medicine & Institute of Laboratory Medicine, Children's and Women's Health, Trondheim 2008. Dissertations at the Faculty of Medicine, ISSN 0805-7680; 370 ISBN 978-82-471-1248-9